Background Increasing evidence implicates microbiome involvement in the development
and progression of pancreatic ductal adenocarcinoma (PDAC). Studies suggest that reflux of …

Pancreatic cancer, predominantly pancreatic ductal adenocarcinoma (PDAC), is one of the
most malignant tumors of the digestive system. Emerging evidence suggests the …

We delve into the critical role of the gut microbiota and its metabolites in the pathogenesis
and progression of hepatobiliary and pancreatic (HBP) cancers, illuminating an urgent need …

Recent studies of the human microbiome have offered new insights into how the microbiome
can impact cancer development and treatment. Specifically, in pancreatic ductal …

Emerging evidence implicates microbiome involvement in the development of pancreatic
cancer (PaCa). Here, we investigate whether increases in circulating microbial-related …

Pancreatic cancer is the seventh leading cause of cancer-related death worldwide, with a 5
year survival rate as low as 9%. One factor complicating the management of pancreatic …

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer characterized by
late diagnosis, rapid progression, and a high mortality rate. Its complex biology …

Simple Summary This review summarizes the current literature related to the microbiome
and pancreatic ductal adenocarcinoma (PDAC). The aim of this review is to explore the …

Pancreatic ductal adenocarcinoma is the third leading cause of cancer-related death in the
United States. As one of the most lethal cancer types, the prognosis for patients diagnosed …

Pancreatic adenocarcinoma is one of the most lethal cancers in both men and women, with
a median five-year survival of around 5%. Therefore, pancreatic adenocarcinoma represents …